VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) 2015 further to our letters dated 19.03.2024 & 17.05.2024 we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 06th Day of September 2024 at Hyderabad inter alia to consider and approve (1) audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March 2024 (2) Board Report (3) AGM for FY2024 & related matters. Further we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.04.2024 to till 48 hours after the declaration of audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March 2024. Kindly take the above information on records